Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An idiotype determinant is the unique collection of antigenic features, known as idiotopes, located within the variable regions of an immunoglobulin or T-cell receptor (TCR) molecule. These determinants are formed by the specific amino acid sequences of the complementarity-determining regions (CDRs) that define the molecule's antigen-binding specificity (Janeway et al., 2001). In clinical oncology, particularly for B-cell malignancies like follicular lymphoma and multiple myeloma, the idiotype expressed by the malignant clone serves as a strictly tumor-specific antigen, as it is unique to the progeny of the original transformed cell and absent from healthy tissues (Levy, 1999). This extreme specificity has made idiotype determinants a primary target for personalized immunotherapy, most notably in the form of idiotype vaccines where a patient's own tumor-derived protein is used to stimulate an anti-tumor immune response (Schuster et al., 2011). Despite their potential, therapeutic challenges include the requirement for highly individualized and costly manufacturing processes, as well as the risk of tumor escape through the selection of clones that no longer express the targeted idiotype (Bendig et al., 2010).
Active immunization inducing a host immune response against patient-specific clonal antigens; Passive immunization using anti-idiotype antibodies to mimic antigens or block receptors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Idiotype determinant (Id).